Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

53BP1 Supports Immunoglobulin Class Switch Recombination Independently of Its DNA Double-Strand Break End Protection Function.

Sundaravinayagam D, Rahjouei A, Andreani M, Tupiņa D, Balasubramanian S, Saha T, Delgado-Benito V, Coralluzzo V, Daumke O, Di Virgilio M.

Cell Rep. 2019 Aug 6;28(6):1389-1399.e6. doi: 10.1016/j.celrep.2019.06.035.

2.

Characterization of the novel HLA-DRB3*02:96 allele by sequencing-based typing.

Blouin L, Andreani M, Battarra M, Guidicelli G, Visentin J.

HLA. 2019 Aug 5. doi: 10.1111/tan.13653. [Epub ahead of print]

PMID:
31381268
3.

Characterization of the novel HLA-DQA1*01:27 allele by sequencing-based typing.

Ralazamahaleo M, Andreani M, Di Luzio A, Guidicelli G, Visentin J.

HLA. 2019 Oct;94(4):392-393. doi: 10.1111/tan.13647. Epub 2019 Aug 12.

PMID:
31369206
4.

Characterization of the novel HLA-DPA1*01:20 allele by sequencing-based typing.

Cargou M, Andreani M, Testa G, Guidicelli G, Visentin J.

HLA. 2019 Oct;94(4):396-397. doi: 10.1111/tan.13648. Epub 2019 Aug 12.

PMID:
31369198
5.

High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.

Seitz-Polski B, Dahan K, Debiec H, Rousseau A, Andreani M, Zaghrini C, Ticchioni M, Rosenthal A, Benzaken S, Bernard G, Lambeau G, Ronco P, Esnault VLM.

Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1173-1182. doi: 10.2215/CJN.11791018. Epub 2019 Jul 24.

PMID:
31340979
6.

Characterization of the novel HLA-DQA1*01:22 allele by sequencing-based typing.

Cargou M, Andreani M, Troiano M, Guidicelli G, Visentin J.

HLA. 2019 Sep;94(3):333-334. doi: 10.1111/tan.13577. Epub 2019 May 26.

PMID:
31074199
7.

Characterization of the novel HLA-DPA1*02:15 allele by sequencing-based typing.

Blouin L, Andreani M, Locatelli F, Guidicelli G, Visentin J.

HLA. 2019 Aug;94(2):179-180. doi: 10.1111/tan.13573. Epub 2019 May 26.

PMID:
31070010
8.

Characterization of the novel HLA-DQA1*01:25 allele by sequencing-based typing.

Cargou M, Andreani M, Galluccio T, Guidicelli G, Visentin J.

HLA. 2019 Aug;94(2):174-175. doi: 10.1111/tan.13568. Epub 2019 Jun 3.

PMID:
31069996
9.

Characterization of the novel HLA-DQA1*01:01:05 allele by sequencing-based typing.

Ralazamahaleo M, Andreani M, Giustiniani P, Guidicelli G, Visentin J.

HLA. 2019 Aug;94(2):172-173. doi: 10.1111/tan.13569. Epub 2019 May 22.

PMID:
31069964
10.

High-resolution HLA typing identifies a new 'super responder' subgroup of HLA-C*06:02-positive psoriatic patients: HLA-C*06:02/HLA-C*04, in response to ustekinumab.

Talamonti M, D'Adamio S, Galluccio T, Andreani M, Pastorino R, Egan CG, Bianchi L, Galluzzo M.

J Eur Acad Dermatol Venereol. 2019 May 8. doi: 10.1111/jdv.15659. [Epub ahead of print] No abstract available.

PMID:
31066090
11.

Characterization of the novel HLA-DRB3*02:02:17 allele by sequencing-based typing.

Cargou M, Andreani M, Battarra M, Guidicelli G, Visentin J.

HLA. 2019 Aug;94(2):170-171. doi: 10.1111/tan.13566. Epub 2019 May 17.

PMID:
31056835
12.

Rituximab bioavailability in primary membranous nephropathy.

Boyer-Suavet S, Andreani M, Cremoni M, Brglez V, Benzaken S, Bernard G, Nachman P, Esnault V, Seitz-Polski B.

Nephrol Dial Transplant. 2019 Mar 30. pii: gfz041. doi: 10.1093/ndt/gfz041. [Epub ahead of print] No abstract available.

PMID:
30929012
13.

Identification of the novel HLA-A*01:289 allele in an Italian patient.

Galluccio T, Locatelli F, Troiano M, Testa G, Andreani M.

HLA. 2019 Jun;93(6):484-485. doi: 10.1111/tan.13497. Epub 2019 Mar 24.

PMID:
30784234
14.

Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.

Massa R, Greco G, Testi M, Rastelli E, Terracciano C, Frezza E, Garibaldi M, Marfia GA, Locatelli F, Mercuri NB, Pompeo E, Antonini G, Andreani M.

J Neurol. 2019 Apr;266(4):982-989. doi: 10.1007/s00415-019-09225-z. Epub 2019 Feb 11.

PMID:
30741378
15.

Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.

Osoegawa K, Vayntrub TA, Wenda S, De Santis D, Barsakis K, Ivanova M, Hsu S, Barone J, Holdsworth R, Diviney M, Askar M, Willis A, Railton D, Laflin S, Gendzekhadze K, Oki A, Sacchi N, Mazzocco M, Andreani M, Ameen R, Stavropoulos-Giokas C, Dinou A, Torres M, Dos Santos Francisco R, Serra-Pages C, Goodridge D, Balladares S, Bettinotti MP, Iglehart B, Kashi Z, Martin R, Saw CL, Ragoussis J, Downing J, Navarrete C, Chong W, Saito K, Petrek M, Tokic S, Padros K, Beatriz Rodriguez M, Zakharova V, Shragina O, Marino SR, Brown NK, Shiina T, Suzuki S, Spierings E, Zhang Q, Yin Y, Morris GP, Hernandez A, Ruiz P, Khor SS, Tokunaga K, Geretz A, Thomas R, Yamamoto F, Mallempati KC, Gangavarapu S, Kanga U, Tyagi S, Marsh SGE, Bultitude WP, Liu X, Cao D, Penning M, Hurley CK, Cesbron A, Mueller C, Mytilineos J, Weimer ET, Bengtsson M, Fischer G, Hansen JA, Chang CJ, Mack SJ, Creary LE, Fernandez-Viña MA.

Hum Immunol. 2019 Apr;80(4):228-236. doi: 10.1016/j.humimm.2019.01.009. Epub 2019 Feb 6. Review.

16.

Characterization of the novel HLA-DQA1*05:14 allele by sequencing-based typing.

Cargou M, Andreani M, Troiano M, Guidicelli G, Visentin J.

HLA. 2019 Apr;93(4):241-243. doi: 10.1111/tan.13484. Epub 2019 Feb 27.

PMID:
30734536
17.

Characterization of the novel HLA-DRB3*03:01:07 allele by sequencing-based typing.

Ralazamahaleo M, Andreani M, Galluccio T, Guidicelli G, Visentin J.

HLA. 2019 Apr;93(4):240-241. doi: 10.1111/tan.13481. Epub 2019 Feb 21.

PMID:
30734509
18.

Characterization of the novel HLA-C*07:708 allele by sequencing-based typing.

Cargou M, Andreani M, Battarra M, Guidicelli G, Visentin J.

HLA. 2019 Apr;93(4):235-236. doi: 10.1111/tan.13479. Epub 2019 Feb 27.

PMID:
30729752
19.

Abiotic synthesis of amino acids in the recesses of the oceanic lithosphere.

Ménez B, Pisapia C, Andreani M, Jamme F, Vanbellingen QP, Brunelle A, Richard L, Dumas P, Réfrégiers M.

Nature. 2018 Dec;564(7734):59-63. doi: 10.1038/s41586-018-0684-z. Epub 2018 Nov 7.

PMID:
30405236
20.

The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination.

Delgado-Benito V, Rosen DB, Wang Q, Gazumyan A, Pai JA, Oliveira TY, Sundaravinayagam D, Zhang W, Andreani M, Keller L, Kieffer-Kwon KR, Pękowska A, Jung S, Driesner M, Subbotin RI, Casellas R, Chait BT, Nussenzweig MC, Di Virgilio M.

Mol Cell. 2018 Nov 15;72(4):636-649.e8. doi: 10.1016/j.molcel.2018.08.042. Epub 2018 Oct 4.

21.
22.

The novel HLA-DRB3*02:02:11 allele identified in an Italian individual.

Battarra M, Locatelli F, Galluccio T, Guagnano A, Andreani M.

HLA. 2018 Dec;92(6):423-424. doi: 10.1111/tan.13393. Epub 2018 Nov 7.

PMID:
30225977
23.

Full-length extension of HLA allele sequences by HLA allele-specific hemizygous Sanger sequencing (SSBT).

Voorter CEM, Matern B, Tran TH, Fink A, Vidan-Jeras B, Montanic S, Fischer G, Fae I, de Santis D, Whidborne R, Andreani M, Testi M, Groeneweg M, Tilanus MGJ.

Hum Immunol. 2018 Nov;79(11):763-772. doi: 10.1016/j.humimm.2018.08.004. Epub 2018 Aug 11.

PMID:
30107213
24.

Development and validation of an extended database for yeast identification by MALDI-TOF MS in Argentina.

Taverna CG, Mazza M, Bueno NS, Alvarez C, Amigot S, Andreani M, Azula N, Barrios R, Fernández N, Fox B, Guelfand L, Maldonado I, Murisengo OA, Relloso S, Vivot M, Davel G.

Med Mycol. 2019 Feb 1;57(2):215-225. doi: 10.1093/mmy/myy021.

PMID:
29762695
25.

Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism.

Bertaina A, Andreani M.

Int J Mol Sci. 2018 Feb 22;19(2). pii: E621. doi: 10.3390/ijms19020621. Review.

26.

Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ+/CD19+-depleted grafts.

Gaziev J, Isgrò A, Sodani P, Paciaroni K, De Angelis G, Marziali M, Ribersani M, Alfieri C, Lanti A, Galluccio T, Adorno G, Andreani M.

Blood Adv. 2018 Feb 13;2(3):263-270. doi: 10.1182/bloodadvances.2017012005.

27.

[Glomerular diseases in brief].

Andreani M, Esnault V.

Rev Prat. 2018 Jan;68(1):e13-e14. French. No abstract available.

PMID:
30840405
28.

[Glomerular nephropathy].

Andreani M, Esnault V.

Rev Prat. 2018 Jan;68(1):e3-e12. French. No abstract available.

PMID:
30840404
29.

Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers.

Perri V, Gianchecchi E, Cifaldi L, Pellegrino M, Giorda E, Andreani M, Cappa M, Fierabracci A.

PLoS One. 2017 Dec 13;12(12):e0189615. doi: 10.1371/journal.pone.0189615. eCollection 2017.

30.

The HLA-B landscape of Africa: Signatures of pathogen-driven selection and molecular identification of candidate alleles to malaria protection.

Sanchez-Mazas A, Černý V, Di D, Buhler S, Podgorná E, Chevallier E, Brunet L, Weber S, Kervaire B, Testi M, Andreani M, Tiercy JM, Villard J, Nunes JM.

Mol Ecol. 2017 Nov;26(22):6238-6252. doi: 10.1111/mec.14366. Epub 2017 Oct 16.

PMID:
28950417
31.

A new allele, HLA-DQA1*02:01:02.

Galluccio T, Guagnano A, Stanglino G, Vicenza T, Andreani M.

HLA. 2017 Dec;90(6):376-377. doi: 10.1111/tan.13139. Epub 2017 Sep 20.

PMID:
28873285
32.

Identification of the novel allele, HLA-A*02:653, in an Italian patient.

Condello R, Picardi A, Battarra M, Troiano M, Andreani M.

HLA. 2017 Nov;90(5):300-301. doi: 10.1111/tan.13112. Epub 2017 Sep 21.

PMID:
28786538
33.

Concurrent Aerobic and Resistance Training Has Anti-Inflammatory Effects and Increases Both Plasma and Leukocyte Levels of IGF-1 in Late Middle-Aged Type 2 Diabetic Patients.

Annibalini G, Lucertini F, Agostini D, Vallorani L, Gioacchini A, Barbieri E, Guescini M, Casadei L, Passalia A, Del Sal M, Piccoli G, Andreani M, Federici A, Stocchi V.

Oxid Med Cell Longev. 2017;2017:3937842. doi: 10.1155/2017/3937842. Epub 2017 Jun 21.

34.

The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy.

Picardi A, Arcese W, Pollichieni S, Di Piazza F, Mangione I, Gallina AM, Cerretti R, Cudillo L, De Angelis G, Mengarelli A, Dentamaro T, Tirindelli MC, Chierichini A, Ferrari A, Marciano R, Andreani M, Bonifazi F, Sacchi N.

Transfusion. 2017 Jul;57(7):1734-1743. doi: 10.1111/trf.14131. Epub 2017 Jun 13.

PMID:
28608367
35.

Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.

Gaziev J, Marziali S, Paciaroni K, Isgrò A, Di Giuliano F, Rossi G, Marziali M, De Angelis G, Alfieri C, Ribersani M, Andreani M, Palmieri MG, Placidi F, Romigi A, Izzi F, Floris R, Mercuri NB.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1531-1540. doi: 10.1016/j.bbmt.2017.05.033. Epub 2017 Jul 3.

36.

A new allele, HLA-A*03:275N.

Battarra M, Condello R, Galluccio T, Stellitano C, Andreani M.

HLA. 2017 Aug;90(2):109-110. doi: 10.1111/tan.13042. Epub 2017 Apr 5.

PMID:
28382774
37.

Identification of the new HLA-DQA1*01:15N allele in an Italian patient.

Battarra M, Condello R, Testi M, Stellitano C, Andreani M.

HLA. 2017 Aug;90(2):130-131. doi: 10.1111/tan.13024. Epub 2017 Mar 26.

PMID:
28345312
38.

Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia.

Andreani M, Testi M, Sodani P, Troiano M, Di Luzio A, Testa G, Falco M, Poggi E, Gaziev J, Piazza A.

Mediterr J Hematol Infect Dis. 2017 Mar 1;9(1):e2017020. doi: 10.4084/MJHID.2017.020. eCollection 2017. No abstract available.

39.

Identification of the new C*07:555 allele in an unrelated donor for HSCT.

Condello R, Battarra M, Testi M, Testa G, Andreani M.

HLA. 2017 Mar;89(3):167-168. doi: 10.1111/tan.12964. Epub 2017 Feb 1.

PMID:
28145086
40.

Common and well-documented HLA alleles over all of Europe and within European sub-regions: A catalogue from the European Federation for Immunogenetics.

Sanchez-Mazas A, Nunes JM, Middleton D, Sauter J, Buhler S, McCabe A, Hofmann J, Baier DM, Schmidt AH, Nicoloso G, Andreani M, Grubic Z, Tiercy JM, Fleischhauer K.

HLA. 2017 Feb;89(2):104-113. doi: 10.1111/tan.12956.

PMID:
28102034
41.

Characterization of the novel HLA-C*02:106 allele in a hematopoietic stem cell volunteer donor.

Testi M, Battarra M, Catalano M, Troiano M, Andreani M.

HLA. 2016 Jul;88(1-2):52-3. doi: 10.1111/tan.12826. Epub 2016 Jun 10.

PMID:
27283262
42.

HLA-C*18:01: A Rare Allele in the European Caucasian Population Coinciding with Difficult-to-Treat Plaque Psoriasis.

Galluzzo M, Andreani M, Testi M, Chimenti S, Talamonti M.

Mol Diagn Ther. 2016 Jun;20(3):227-30. doi: 10.1007/s40291-016-0199-y.

PMID:
27038214
43.

A nucleotide insertion in Exon 2 is responsible for a new HLA-DRB1 null allele, HLA-DRB1*14:166N.

Testi M, Troiano M, Paladini E, Di Luzio A, Andreani M.

HLA. 2016 Jan;87(1):60. doi: 10.1111/tan.12705. Epub 2015 Nov 17.

PMID:
26814418
44.

Mixed chimerism evolution is associated with T regulatory type 1 (Tr1) cells in a β-thalassemic patient after haploidentical haematopoietic stem cell transplantation.

Andreani M, Gianolini ME, Testi M, Battarra M, Tiziana G, Morrone A, Sodani P, Lucarelli G, Roncarolo MG, Gregori S.

Chimerism. 2014;5(3-4):75-9. doi: 10.1080/19381956.2015.1103423. Epub 2015 Dec 9.

45.

Optimal Outcomes in Young Class 3 Patients With Thalassemia Undergoing HLA-Identical Sibling Bone Marrow Transplantation.

Gaziev J, Isgrò A, Sodani P, Marziali M, Paciaroni K, Gallucci C, De Angelis G, Andreani M, Testi M, Alfieri C, Ribersani M, Galluccio T, Battarra MR, Morrone A, Lucarelli G.

Transplantation. 2016 Apr;100(4):925-32. doi: 10.1097/TP.0000000000000928.

PMID:
26457600
46.

HLA-A-B-C-DRB1-DQB1 phased haplotypes in 124 Nigerian families indicate extreme HLA diversity and low linkage disequilibrium in Central-West Africa.

Testi M, Battarra M, Lucarelli G, Isgro A, Morrone A, Akinyanju O, Wakama T, Nunes JM, Andreani M, Sanchez-Mazas A.

Tissue Antigens. 2015 Oct;86(4):285-92. doi: 10.1111/tan.12642. Epub 2015 Aug 24.

PMID:
26300115
47.

Sequence-based typing characterization of the novel HLA-DRB3*01:16 allele, identified in an Italian family.

Testi M, Battarra M, Di Luzio A, Stellitano C, Andreani M.

Tissue Antigens. 2015 Oct;86(4):307-8. doi: 10.1111/tan.12638. Epub 2015 Aug 10.

PMID:
26256782
48.

Luminex-Based Methods in High-Resolution HLA Typing.

Testi M, Andreani M.

Methods Mol Biol. 2015;1310:231-45. doi: 10.1007/978-1-4939-2690-9_19.

PMID:
26024639
49.

Validation of Normalizations, Scaling, and Photofading Corrections for FRAP Data Analysis.

Kang M, Andreani M, Kenworthy AK.

PLoS One. 2015 May 27;10(5):e0127966. doi: 10.1371/journal.pone.0127966. eCollection 2015.

50.

HLA-C*07:02:60, a variant of HLA-C*07 found in an unrelated volunteer stem cell donor.

Testi M, Andreani M, Galluccio T, Guagnano A, Paladini E.

Tissue Antigens. 2015 Jan;85(1):77-8. doi: 10.1111/tan.12484.

PMID:
25597904

Supplemental Content

Loading ...
Support Center